Education
About Us
Working with TipRanks
Follow Us
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 385.69M | $ 270.60M | $ 50.04M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 352.39M | $ 244.53M | $ 44.84M | $ 0.00 | $ 0.00 |
| Operating Income | $ -280.56M | $ -231.82M | $ -179.80M | $ -124.71M | $ -99.14M |
| EBITDA | $ -272.60M | $ -224.99M | $ -175.40M | $ -124.63M | $ -100.31M |
| Net Income | $ -287.22M | $ -239.24M | $ -187.13M | $ -130.40M | $ -102.90M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 315.35M | $ 386.19M | $ 200.84M | $ 86.47M | $ 183.88M |
| Total Assets | $ 568.50M | $ 588.24M | $ 331.48M | $ 87.79M | $ 186.13M |
| Total Debt | $ 192.96M | $ 186.37M | $ 94.68M | $ 49.71M | $ 50.12M |
| Net Debt | $ -122.40M | $ -199.82M | $ -106.16M | $ -36.76M | $ -133.75M |
| Total Liabilities | $ 511.48M | $ 397.26M | $ 221.92M | $ 72.15M | $ 72.34M |
| Stockholders' Equity | $ 57.02M | $ 190.98M | $ 109.56M | $ 15.63M | $ 113.79M |
| Cash Flow | |||||
| Free Cash Flow | $ -128.68M | $ -145.66M | $ -117.21M | $ -108.53M | $ -78.50M |
| Operating Cash Flow | $ -128.41M | $ -145.08M | $ -116.51M | $ -108.23M | $ -78.46M |
| Investing Cash Flow | $ -270.00K | $ -582.00K | $ -53.70M | $ -308.00K | $ -45.89K |
| Financing Cash Flow | $ 57.84M | $ 331.01M | $ 284.58M | $ 11.13M | $ 42.41M |